ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)
Clinical trial NCT05736861 · COMPLETED
Trial details
- NCT number
- NCT05736861
- Sponsor
- Susanna Naggie, MD
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-08
- Primary completion
- 2022-03-15
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.